[go: up one dir, main page]

ES2139883T3 - Microgranulos de derivados de 5-nitroimidazol. - Google Patents

Microgranulos de derivados de 5-nitroimidazol.

Info

Publication number
ES2139883T3
ES2139883T3 ES95907683T ES95907683T ES2139883T3 ES 2139883 T3 ES2139883 T3 ES 2139883T3 ES 95907683 T ES95907683 T ES 95907683T ES 95907683 T ES95907683 T ES 95907683T ES 2139883 T3 ES2139883 T3 ES 2139883T3
Authority
ES
Spain
Prior art keywords
microgranules
medicinal
nitroimidazole derivatives
hand
gastrointestinal tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95907683T
Other languages
English (en)
Inventor
Gerard Leduc
Patrice Debregeas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/fr
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Application granted granted Critical
Publication of ES2139883T3 publication Critical patent/ES2139883T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA FORMA GALENICA DE DERIVADOS DE 5-NITRO IMIDAZOL CARACTERIZADA POR QUE COMPRENDE UNA ASOCIACION DE MICROGRANULOS DE LIBERACION PROLONGADA, LAS COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y LOS MICROGRANULOS USADOS COMO INTERMEDIOS EN LAS PREPARACION DE LA FORMA SEGUN LA INVENCION.
ES95907683T 1994-01-14 1995-01-12 Microgranulos de derivados de 5-nitroimidazol. Expired - Lifetime ES2139883T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (fr) 1994-01-14 1994-01-14 Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.

Publications (1)

Publication Number Publication Date
ES2139883T3 true ES2139883T3 (es) 2000-02-16

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95907683T Expired - Lifetime ES2139883T3 (es) 1994-01-14 1995-01-12 Microgranulos de derivados de 5-nitroimidazol.

Country Status (19)

Country Link
JP (1) JPH09507499A (es)
KR (1) KR100320140B1 (es)
CN (1) CN1088357C (es)
AT (1) ATE187068T1 (es)
AU (1) AU705570B2 (es)
BR (1) BR9506507A (es)
CZ (1) CZ286080B6 (es)
DE (1) DE69513632T2 (es)
DK (1) DK0739201T3 (es)
ES (1) ES2139883T3 (es)
MA (1) MA23429A1 (es)
MX (1) MX9602772A (es)
NZ (1) NZ279238A (es)
OA (1) OA10583A (es)
PL (1) PL178424B1 (es)
PT (1) PT739201E (es)
RU (1) RU2152212C1 (es)
SK (1) SK282066B6 (es)
UA (1) UA28031C2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
CA2082398C (en) * 1990-05-14 2004-06-29 Gary R. Jernberg Surgical implant and method incorporating chemotherapeutic agents

Also Published As

Publication number Publication date
BR9506507A (pt) 1997-09-09
ATE187068T1 (de) 1999-12-15
OA10583A (en) 2002-07-10
DE69513632D1 (de) 2000-01-05
CN1088357C (zh) 2002-07-31
SK282066B6 (sk) 2001-10-08
AU705570B2 (en) 1999-05-27
PT739201E (pt) 2000-05-31
MA23429A1 (fr) 1995-10-01
UA28031C2 (uk) 2000-10-16
JPH09507499A (ja) 1997-07-29
DE69513632T2 (de) 2000-04-06
KR100320140B1 (ko) 2002-07-02
PL315530A1 (en) 1996-11-12
DK0739201T3 (da) 2000-05-01
SK91496A3 (en) 1996-12-04
CN1138826A (zh) 1996-12-25
RU2152212C1 (ru) 2000-07-10
MX9602772A (es) 1997-05-31
CZ286080B6 (cs) 2000-01-12
PL178424B1 (pl) 2000-04-28
CZ205596A3 (en) 1996-10-16
AU1580395A (en) 1995-08-01
NZ279238A (en) 1998-03-25

Similar Documents

Publication Publication Date Title
TR199800602A3 (tr) Dithiolan türevleri, hazirlanmalari ve terapötik etkileri.
MX9707334A (es) Composicion farmaceutica que contiene hidratos de carbonato de lantano seleccionados.
ID21115A (id) Isokuinolin-3-karboksamida tersubstitusi, pembuatannya serta penggunaannya sebagai obat
FR15C0024I2 (fr) Indolinones substituees en position 6, leur preparation et leur utilisation en tant que medicaments
HK1036408A1 (en) Indolyl-3-glyoxylic acid derivatives with antitumoral activity.
DE69829008D1 (de) Nasen-, Mund- und Rachenraumkanüle
DE50010677D1 (de) Neuartige aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
DE69836514D1 (de) Elektrodenkörper, mit diesem versehener Akkumulator, sowie Herstellung des Elektrodenkörpers und des Akkumulators
EE200100009A (et) Bensimidasoolid, nende valmistamine ja kasutamineravimitena
ATE306254T1 (de) Zubereitungen mit verbesserter kontrollierter freisetzung
DE69826684D1 (de) Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen
IL126714A (en) Use of cells, organs or components thereof for the preparation of a pharmaceutical composition for establishing selective immune downregulation
USD404097S (en) Practice bat
HUP0100452A2 (hu) Nyálkahártyán keresztül adagolható levoszimendán-készítmények
ATE187890T1 (de) Ligandgerichtete enzyme-prodrug therapie
ES2139883T3 (es) Microgranulos de derivados de 5-nitroimidazol.
ZA973016B (en) Transdermally administered acetylcysteine as mucolytic agent.
ZA976619B (en) Benzimidazole derivatives, their preparation and their therapeutic applications.
NZ501832A (en) Angiotensin-peptide carrier conjugates for treating diseases associated with the renin-angiotensin system
DE68906245D1 (de) Therapeutisches mittel gegen aids.
HK1045514A1 (en) Optically pure camptothecin analogues and composition and use thereof.
BR9907195A (pt) " formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos "
RU96115480A (ru) Лекарственное средство, обладающее холелитолитическим действием
NL1013323A1 (nl) Stroomafnemer en koppelstuk daarvoor.
MY128686A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 739201

Country of ref document: ES